The ApoA5 levels and the prevalence of hypertriglyceridemia are in an inverted “U-shaped” correlation, but there is no significant difference between ApoA5 levels, NAFLD, and metabolic syndrome. Here, APOA5 is linked to metabolic dysfunction-associated steatotic liver disease.